Clinical Trials List
2022-11-30 - 2027-03-31
Phase I/II
Recruiting4
ICD-10C69.40
Malignant neoplasm of unspecified ciliary body
ICD-10C69.41
Malignant neoplasm of right ciliary body
ICD-10C69.42
Malignant neoplasm of left ciliary body
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
WORLDWIDE CLINICAL TRIALS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 朱本元 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Tsung-Lun Lee Division of Hematology & Oncology
- 戴世光 Division of Hematology & Oncology
- Chia-Fan Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chen-Chi Wang Division of Radiation Therapy
- CHENG-HSIEN LIN Division of Radiation Therapy
- 鄭皓升 Division of Radiation Therapy
- ZHENG-WEI ZHOU Division of Radiation Therapy
- 趙勇全 Division of Radiation Therapy
- 李權 Division of Radiation Therapy
- 陳建志 Division of Radiation Therapy
- 林玟君 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Yu Lien Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
220 participants
